CLINICAL APPLICATION OF ARGATROBAN AS AN ALTERNATIVE ANTICOAGULANT FOR EXTRACORPOREAL CIRCULATION
- 1 April 2000
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 14 (2) , 445-457
- https://doi.org/10.1016/s0889-8588(05)70144-1
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Argatroban as a potential anticoagulant in cardiopulmonary bypass-studies in a dog modelCardiovascular Surgery, 1999
- Thrombin and AntithromboticsSeminars in Thrombosis and Hemostasis, 1998
- Extracorporeal membrane oxygenation: Preliminary results in patients with postcardiotomy cardiogenic shockThe Annals of Thoracic Surgery, 1994
- Response to heparinization in adults and children undergoing cardiac operationsThe Annals of Thoracic Surgery, 1992
- Heparin-induced thrombocytopenia in open heart surgical patients: Sequelae of late recognitionThe Annals of Thoracic Surgery, 1992
- Review articles : Extracorporeal membrane oxygenation (ECMO): prolonged bedside cardiopulmonary bypassPerfusion, 1990
- Heparin Free Long-term Extracorporeal Circulation Using Bioactive SurfacesAnnual Northeast Bioengineering Conference, 1989
- Percutaneous cardiopulmonary bypass: Application and indication for useThe Annals of Thoracic Surgery, 1989
- Percutaneous Initiation of Cardiopulmonary BypassThe Annals of Thoracic Surgery, 1983
- Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. The importance of stereo-structure of its hydrophobic carboxamide portionBiochemical and Biophysical Research Communications, 1981